Annual Operating Profit
-$8.45 M
+$6.34 M+42.88%
01 June 2024
Summary:
Kintara Therapeutics annual operaing income is currently -$8.45 million, with the most recent change of +$6.34 million (+42.88%) on 01 June 2024. During the last 3 years, it has risen by +$13.12 million (+60.82%).KTRA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$2.38 M
-$300.00 K-14.39%
01 June 2024
Summary:
Kintara Therapeutics quarterly operating income is currently -$2.38 million, with the most recent change of -$300.00 thousand (-14.39%) on 01 June 2024. Over the past year, it has increased by +$577.00 thousand (+19.48%).KTRA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$8.45 M
+$964.00 K+10.24%
01 June 2024
Summary:
Kintara Therapeutics TTM operating income is currently -$8.45 million, with the most recent change of +$964.00 thousand (+10.24%) on 01 June 2024. Over the past year, it has increased by +$4.66 million (+35.55%).KTRA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KTRA Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.9% | +19.5% | +35.5% |
| 3 y3 years | +60.8% | +60.1% | +65.7% |
| 5 y5 years | -0.6% | -45.9% | -5.3% |
KTRA Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | >+9999.0% | >+9999.0% | >+9999.0% |
Kintara Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | -$8.45 M(-42.9%) | -$2.38 M(+14.4%) | -$8.45 M(-10.2%) |
| Mar 2024 | - | -$2.08 M(+104.6%) | -$9.41 M(-11.4%) |
| Dec 2023 | - | -$1.02 M(-65.6%) | -$10.63 M(-18.9%) |
| Sept 2023 | - | -$2.96 M(-11.6%) | -$13.11 M(-11.4%) |
| June 2023 | -$14.80 M(-34.8%) | -$3.35 M(+1.4%) | -$14.80 M(-12.5%) |
| Mar 2023 | - | -$3.30 M(-5.6%) | -$16.91 M(-10.8%) |
| Dec 2022 | - | -$3.50 M(-24.7%) | -$18.96 M(-11.2%) |
| Sept 2022 | - | -$4.65 M(-14.9%) | -$21.36 M(-5.8%) |
| June 2022 | -$22.68 M(+5.1%) | -$5.46 M(+1.9%) | -$22.68 M(-5.2%) |
| Mar 2022 | - | -$5.36 M(-9.1%) | -$23.92 M(-5.0%) |
| Dec 2021 | - | -$5.89 M(-1.3%) | -$25.17 M(+2.1%) |
| Sept 2021 | - | -$5.97 M(-10.8%) | -$24.65 M(+14.3%) |
| June 2021 | -$21.57 M(+164.9%) | -$6.70 M(+1.4%) | -$21.57 M(+22.3%) |
| Mar 2021 | - | -$6.61 M(+22.8%) | -$17.64 M(+35.6%) |
| Dec 2020 | - | -$5.38 M(+86.0%) | -$13.01 M(+38.4%) |
| Sept 2020 | - | -$2.89 M(+4.5%) | -$9.40 M(+15.4%) |
| June 2020 | -$8.14 M(-3.0%) | -$2.77 M(+40.0%) | -$8.14 M(-1.6%) |
| Mar 2020 | - | -$1.98 M(+11.9%) | -$8.28 M(+3.8%) |
| Dec 2019 | - | -$1.77 M(+8.0%) | -$7.97 M(-0.7%) |
| Sept 2019 | - | -$1.64 M(-43.6%) | -$8.03 M(-4.4%) |
| June 2019 | -$8.40 M(-24.8%) | -$2.90 M(+73.5%) | -$8.40 M(+6.2%) |
| Mar 2019 | - | -$1.67 M(-8.3%) | -$7.91 M(-13.8%) |
| Dec 2018 | - | -$1.82 M(-9.1%) | -$9.17 M(-12.7%) |
| Sept 2018 | - | -$2.01 M(-16.7%) | -$10.50 M(-6.0%) |
| June 2018 | -$11.17 M(+34.3%) | -$2.41 M(-18.0%) | -$11.17 M(-3.4%) |
| Mar 2018 | - | -$2.93 M(-7.0%) | -$11.56 M(+11.0%) |
| Dec 2017 | - | -$3.15 M(+17.7%) | -$10.41 M(+16.3%) |
| Sept 2017 | - | -$2.68 M(-4.1%) | -$8.95 M(+7.6%) |
| June 2017 | -$8.32 M | -$2.79 M(+56.7%) | -$8.32 M(+10.0%) |
| Mar 2017 | - | -$1.78 M(+5.4%) | -$7.56 M(+5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | - | -$1.69 M(-17.4%) | -$7.20 M(+0.2%) |
| Sept 2016 | - | -$2.05 M(+0.7%) | -$7.19 M(+15.6%) |
| June 2016 | -$6.21 M(+31.5%) | -$2.04 M(+43.3%) | -$6.21 M(+15.6%) |
| Mar 2016 | - | -$1.42 M(-15.4%) | -$5.38 M(+5.5%) |
| Dec 2015 | - | -$1.68 M(+55.8%) | -$5.10 M(+8.8%) |
| Sept 2015 | - | -$1.08 M(-9.9%) | -$4.69 M(-0.8%) |
| June 2015 | -$4.72 M(+71.8%) | -$1.20 M(+4.8%) | -$4.72 M(+33.9%) |
| Mar 2015 | - | -$1.14 M(-9.9%) | -$3.53 M(-11.2%) |
| Dec 2014 | - | -$1.27 M(+13.6%) | -$3.97 M(+1.7%) |
| Sept 2014 | - | -$1.12 M(-29.6%) | -$3.90 M(-38.3%) |
| June 2014 | -$2.75 M(-56.3%) | - | - |
| Mar 2014 | - | -$1.59 M(+31.9%) | -$6.33 M(+0.5%) |
| Dec 2013 | -$6.29 M(>+9900.0%) | -$1.20 M(-7.6%) | -$6.29 M(+23.5%) |
| Sept 2013 | - | -$1.30 M(-41.9%) | -$5.10 M(+34.2%) |
| June 2013 | - | -$2.24 M(+44.2%) | -$3.80 M(+143.4%) |
| Mar 2013 | - | -$1.55 M(>+9900.0%) | -$1.56 M(>+9900.0%) |
| Dec 2012 | - | -$3200.00(-23.8%) | -$11.50 K(-40.1%) |
| Sept 2012 | - | -$4200.00(+320.0%) | -$19.20 K(+1.6%) |
| June 2012 | - | -$1000.00(-67.7%) | -$18.90 K(-23.5%) |
| June 2012 | -$18.90 K(-42.9%) | - | - |
| Mar 2012 | - | -$3100.00(-71.6%) | -$24.70 K(-2.8%) |
| Dec 2011 | - | -$10.90 K(+179.5%) | -$25.40 K(-12.7%) |
| Sept 2011 | - | -$3900.00(-42.6%) | -$29.10 K(-12.1%) |
| June 2011 | -$33.10 K(+491.1%) | -$6800.00(+78.9%) | -$33.10 K(+22.1%) |
| Mar 2011 | - | -$3800.00(-74.0%) | -$27.10 K(+15.8%) |
| Dec 2010 | - | -$14.60 K(+84.8%) | -$23.40 K(+125.0%) |
| Sept 2010 | - | -$7900.00(+887.5%) | -$10.40 K(+316.0%) |
| June 2010 | -$5600.00 | -$800.00(+700.0%) | -$2500.00(+47.1%) |
| Mar 2010 | - | -$100.00(-93.8%) | -$1700.00(+6.3%) |
| Dec 2009 | - | -$1600.00 | -$1600.00 |
FAQ
- What is Kintara Therapeutics annual operaing income?
- What is the all time high annual operating profit for Kintara Therapeutics?
- What is Kintara Therapeutics annual operating profit year-on-year change?
- What is Kintara Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Kintara Therapeutics?
- What is Kintara Therapeutics quarterly operating profit year-on-year change?
- What is Kintara Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Kintara Therapeutics?
- What is Kintara Therapeutics TTM operating profit year-on-year change?
What is Kintara Therapeutics annual operaing income?
The current annual operating profit of KTRA is -$8.45 M
What is the all time high annual operating profit for Kintara Therapeutics?
Kintara Therapeutics all-time high annual operaing income is -$5600.00
What is Kintara Therapeutics annual operating profit year-on-year change?
Over the past year, KTRA annual operaing income has changed by +$6.34 M (+42.88%)
What is Kintara Therapeutics quarterly operating income?
The current quarterly operating profit of KTRA is -$2.38 M
What is the all time high quarterly operating profit for Kintara Therapeutics?
Kintara Therapeutics all-time high quarterly operating income is -$100.00
What is Kintara Therapeutics quarterly operating profit year-on-year change?
Over the past year, KTRA quarterly operating income has changed by +$577.00 K (+19.48%)
What is Kintara Therapeutics TTM operating income?
The current TTM operating profit of KTRA is -$8.45 M
What is the all time high TTM operating profit for Kintara Therapeutics?
Kintara Therapeutics all-time high TTM operating income is -$1600.00
What is Kintara Therapeutics TTM operating profit year-on-year change?
Over the past year, KTRA TTM operating income has changed by +$4.66 M (+35.55%)